Sandbox:DAMI: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
===Risk factors=== | ===Risk factors=== | ||
* | |||
====Common Risk Factors==== | |||
* Drugs (12765) | * Drugs (12765) | ||
** Spironolactone | ** Spironolactone | ||
| Line 25: | Line 27: | ||
* Chronic Kidney disease | * Chronic Kidney disease | ||
* Tumors | * Tumors | ||
====Less Common Risk Factors==== | ====Less Common Risk Factors==== | ||
* Feminizing adrenal tumors | |||
* Ectopic hCG | |||
* Disorders of sex development | |||
* Familial prepubertal gynecomastia | |||
=== Causes === | === Causes === | ||
Revision as of 14:52, 18 May 2017
Gynecomastia
Risk factors
Common Risk Factors
- Drugs (12765)
- Idiopathic
- Cirrhosis
- Starvation and Refeeding
- Male hypogonadism
- Testicular neoplasms
- Hyperthyroidism
- Chronic Kidney disease
- Tumors
Less Common Risk Factors
- Feminizing adrenal tumors
- Ectopic hCG
- Disorders of sex development
- Familial prepubertal gynecomastia
Causes
History and Symptoms
Physical Examination
References
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.